1: Ohtake N, Okamoto O, Mitomo R, Kato Y, Yamamoto K, Haga Y, Fukatsu H, Nakagawa S. 1 beta-Methyl-2-(5-substituted pyrrolidin-3-ylthio)carbapenems. 3. Synthesis and antibacterial activity of BO-2727 and its related compounds. J Antibiot (Tokyo). 1997 Jul;50(7):598-613. PubMed PMID: 9711251.
2: Inoue K, Hamana Y, Mitsuhashi S. In vitro antibacterial activity and beta-lactamase stability of a new carbapenem, BO-2727. Antimicrob Agents Chemother. 1995 Oct;39(10):2331-6. PubMed PMID: 8619591; PubMed Central PMCID: PMC162938.
3: Nakagawa S, Hashizume T, Matsuda K, Sanada M, Okamoto O, Fukatsu H, Tanaka N. In vitro activity of a new carbapenem antibiotic, BO-2727, with potent antipseudomonal activity. Antimicrob Agents Chemother. 1993 Dec;37(12):2756-9. PubMed PMID: 8109950; PubMed Central PMCID: PMC192804.
4: Hashizume T, Nakamura K, Nakagawa S. Affinities of BO-2727 for bacterial penicillin-binding proteins and morphological change of gram-negative rods. J Antibiot (Tokyo). 1997 Feb;50(2):139-42. PubMed PMID: 9099223.
5: Shibata K, Adachi Y, Kato E, Nagano R, Fuse A, Hashizume T, Ohtake N, Okamoto O, Nakagawa S. In vitro and in vivo evaluation of BO-2727 against imipenem- and/or meropenem-resistant Pseudomonas aeruginosa. J Antibiot (Tokyo). 1997 Feb;50(2):135-8. PubMed PMID: 9099222.
6: Takano T, Kagami Y, Kuwabara Y, Hata S. Column-switching high-performance liquid chromatographic analysis of BO-2727, a new carbapenem antibiotic, in human plasma and urine by direct injection. J Chromatogr B Biomed Appl. 1994 Jun 17;656(2):353-8. PubMed PMID: 7987487.
7: Barry AL, Fuchs PC. BO-2727, meropenem and imipenem disc diffusion susceptibility testing criteria. J Antimicrob Chemother. 1995 Aug;36(2):444-6. PubMed PMID: 8522478.
8: Nakashima M, Uematsu T, Kosuge K, Nakagawa S, Hata S, Sanada M. Pharmacokinetics and safety of BO-2727, a new injectable 1-beta-methyl carbapenem antibiotic, and its effect on the faecal microflora in healthy male volunteers. J Antimicrob Chemother. 1994 May;33(5):987-98. PubMed PMID: 8089072.
9: Kato Y, Otsuki M, Nishino T. Antibacterial properties of BO-2727, a new carbapenem antibiotic. J Antimicrob Chemother. 1997 Aug;40(2):195-203. PubMed PMID: 9301984.
10: Hazumi N, Fuse A, Matsuda K, Hashizume T, Sanada M. Mechanism of enhanced antipseudomonal activity of BO-2727, a new injectable 1-beta-methyl carbapenem. Antimicrob Agents Chemother. 1995 Mar;39(3):702-6. PubMed PMID: 7793876; PubMed Central PMCID: PMC162608.
11: Mikamo H, Kawazoe K, Izumi K, Sato Y, Tamaya T. In vitro and in vivo antibacterial activities of a new carbapenem BO-2727 for use in obstetrics and gynecology. Chemotherapy. 1998 Jan-Feb;44(1):12-6. PubMed PMID: 9444403.
12: Asahi Y, Miyazaki S, Yamaguchi K. In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem. Antimicrob Agents Chemother. 1995 May;39(5):1030-7. PubMed PMID: 7625784; PubMed Central PMCID: PMC162678.
13: Mori M, Hikida M, Nishihara T, Nasu T, Mitsuhashi S. Comparative stability of carbapenem and penem antibiotics to human recombinant dehydropeptidase-I. J Antimicrob Chemother. 1996 May;37(5):1034-6. PubMed PMID: 8737157.
14: Hazumi N, Kato Y, Hashizume T, Matsuda K. Effects of a beta-lactamase inhibitor, sulbactam, on the activity of carbapenems against Pseudomonas aeruginosa. J Antibiot (Tokyo). 1995 Nov;48(11):1364-7. PubMed PMID: 8557585.
15: Wong BK, Bruhin PJ, Lin JH. Column-switching high-pressure liquid chromatographic method for the determination of a new carbapenem antibiotic, L-739,428, in rat and monkey plasma. J Chromatogr B Biomed Appl. 1994 Apr 22;655(1):158-62. PubMed PMID: 8061826.